BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26033719)

  • 61. Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of
    Satta G; Witney AA; Begum N; Ortiz Canseco J; Boa AN; McHugh TD
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571810
    [No Abstract]   [Full Text] [Related]  

  • 62. A five-year review of prevalence and treatment outcomes of pre-extensively drug-resistant plus additional drug-resistant tuberculosis in the Henan Provincial Tuberculosis Clinical Medicine Research Centre.
    Li Z; Liu F; Chen H; Han Y; You Y; Xie Y; Zhao Y; Tan J; Guo X; Cheng Y; Wang Y; Li J; Cheng M; Xia S; Niu X; Wei L; Wang W
    J Glob Antimicrob Resist; 2022 Dec; 31():328-336. PubMed ID: 36210030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant
    Leung KS; Siu GK; Tam KK; To SW; Rajwani R; Ho PL; Wong SS; Zhao WW; Ma OC; Yam WC
    Front Cell Infect Microbiol; 2017; 7():478. PubMed ID: 29188195
    [No Abstract]   [Full Text] [Related]  

  • 65. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
    Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
    Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
    Shah I; Shah F
    Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis.
    Cheng VW; Leung KS; Kwok JS; Leung RK; Yang KY; Chan RC; Kam KM; Tsui SK
    Microb Drug Resist; 2016 Oct; 22(7):545-551. PubMed ID: 27082669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 72. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
    Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
    Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.
    Wedajo W; Schön T; Bedru A; Kiros T; Hailu E; Mebrahtu T; Yamuah L; Ängeby K; Werngren J; Onyebujoh P; Dagne K; Aseffa A
    BMC Res Notes; 2014 Aug; 7():512. PubMed ID: 25108648
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran.
    Nasiri MJ; Rezaei F; Zamani S; Darban-Sarokhalil D; Fooladi AA; Shojaei H; Feizabadi MM
    Asian Pac J Trop Med; 2014 Mar; 7(3):193-6. PubMed ID: 24507638
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of para-aminosalicylic acid (PAS) on the development of resistance of tubercle bacilli to streptomycin.
    FRIEDMAN B; SALE L; GOLDMAN A
    Am J Med Sci; 1952 Jul; 224(1):53-6. PubMed ID: 14933413
    [No Abstract]   [Full Text] [Related]  

  • 76. Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon.
    Assam-Assam JP; Penlap VB; Cho-Ngwa F; Tedom JC; Ane-Anyangwe I; Titanji VP
    BMC Infect Dis; 2011 Apr; 11():94. PubMed ID: 21496268
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
    Kurbatova EV; Cavanaugh JS; Shah NS; Wright A; Kim H; Metchock B; Van Deun A; Barrera L; Boulahbal F; Richter E; Martín-Casabona N; Arias F; Zemanova I; Drobniewski F; Santos Silva A; Coulter C; Lumb R; Cegielski JP
    Int J Tuberc Lung Dis; 2012; 16(3):355-7. PubMed ID: 22640449
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
    Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
    mBio; 2018 May; 9(3):. PubMed ID: 29844114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.